our philosophy

We build technology in the service of science


We use AI to augment human intelligence. We design our technology to enable scientists to better understand the development of disease mechanisms, discover novel drug targets and make decisions with greater confidence. We believe this approach will measurably improve the success rate of our portfolio, and help us deliver treatments to the patients who need them.



A global and diverse team of technologists and scientists

BenevolentAI brings together a unique cross-section of science and technology teams and a world-renowned board of directors and experienced leadership team in a shared mission: to work together to redefine how drugs are discovered and developed.


Who We are - ESG.jpg


Our strategy for long-term impact

We are committed to weaving ESG stewardship into the fabric of our mission. We concentrate our sustainability efforts around five core levers:

  • Enhance our platform
  • Advance our pipeline
  • Support our partners
  • Invest in our people
  • Reduce our impact on the planet



Industry recognition